



THE EFFECT OF RESTORING GDNF SIGNALING ON 








A thesis submitted to the Johns Hopkins University in conformity with the requirements 









© 2016 Andrew Laychur 






Spermatogonia Stem cells (SSCs) are the foundation of male fertility. A group of 
infertile men lack enough SSCs to maintain sperm production, a phenotype labeled 
Stertoli Cell-Only. Decades of research has implied glial cell line-derived neurotrophic 
factor (GDNF) as a key factor for sustaining SSC and their immediate progeny 
undifferentiated spermatogonia, but more work is necessary to determine GDNF’s 
clinical relevance.  
This thesis examines the impact of inhibition and then restoration of GDNF on the 
differentiation of SSC and undifferentiated spermatogonia. Specifically testing the 
hypothesis that restoring GDNF signaling after 9 days of its inhibition would cause the 
remaining undifferentiated spermatogonia to suppress differentiation thereby restoring 
numbers of SSCs and progenitor spermatogonia in the testis. The Wright lab has 
developed a chemical-genetic approach to inhibit GDNF signaling through its 
intracellular tyrosine receptor kinase RET. Under normal conditions GDNF signaling 
proceeds unaffected but in the presence of a bulky ATP competitive-inhibitor signaling is 
inhibited. This thesis utilized that chemical genetic approach to block GDNF signaling 
for nine days and collects samples at various time points after GDNF inhibition. The 
samples were then processed through immunocytochemistry and analyzed using 
microscopy.  
The results show a varied response in differentiation by cell type. One population 
of undifferentiated spermatogonia, containing mostly progenitor transit amplifying 
undifferentiated spermatogonia, quickly and drastically decreases differentiation. While 
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another population, partially comprised of SSC, had little decrease in differentiation with 
GDNF signal restoration. The combined work implies a restoration of GDNF signaling 
has different effects on SSC and undifferentiated transit amplifying progenitor 
spermatogonia. This nuanced response indicates GDNF may act in coordination with 
other extrinsic signaling molecules in order to sequentially rebuild the numbers of transit 
amplifying progenitor spermatogonia and then the pool of SSCs. 
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The process of making sperm begins with spermatogonial stem cells (SSCs); 
these cells are the foundation for male fertility. Normal human males produce as many as 
1,000 sperm for every heartbeat from puberty until death. Producing this large number of 
highly differentiated cells requires a robust and tightly regulated population of stem and 
progenitor cells (Griswold, Oatley 2013).  Our research is concerned with the regulation 
of SSCs, clinically relevant to a subset of infertile men referred to as Sertoli Cell-Only 
(SCO) (Del Castillo et al. 1947; Gul et al. 2013). Despite this name, many among these 
men possess some SSCs, providing hope for treatment (Sibler et al. 2000). Our research 
strives to elucidate causes and future treatments for these currently incurable cases of 
male infertility.   
Adult stem cells throughout the body are relied upon to replenish tissues with 
cells that are lost either through terminal differentiation (e.g. formation of sperm) or 
through injury. Stem cells are capable of dividing symmetrically to produce two new 
daughter stem cells, thereby increasing stem cell numbers; or asymmetrically, producing 
one stem cell and one differentiating cell (see Figure 1)(Oatley, Brinster 2012). This 
maintains stem cell numbers while providing cells that go on to differentiate.  In the testis, 
properly regulated SSCs are the basis for male fertility. However, the study of SSCs is 
challenging because of the difficulty in distinguishing these cells from their immediate 
progeny, the transit amplifying progenitor spermatogonia. The classical experimental 
proof for the existence of stem cells is that upon transplantation, the cells can reconstitute 
an entire cell lineage. Self-renewing replication of stem cells maintains the stem cell pool, 
and provides cells that differentiate and generate transit amplifying progenitor 
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spermatogonia. The transplantation assay involves depleting the testes of naïve 
spermatogonia and then injecting donor cells into the seminiferous tubules of the testes. 
Expansion of the injected cells and establishment of spermatogenesis proves the presence 
of SSCs in the donor sample (Oatley, Brinster 2008; Brinster, Avarbock 1994).   
Functioning of stem cells is regulated by extracellular and intracellular signals (Li 
and Xie, 2005; Underhill and Bhatia, 2007). The stem cell “niche” refers to a defined 
anatomic region that regulates stem cell renewal and differentiation, and thus how 
particular stem cells function in tissue maintenance and repair without becoming depleted 
(Li, Xie, 2005; David, 2006).  If there is failure of transplantation assays of normal SSCs 
into SCO testes (i.e. failure of the injected cells to reestablish spermatogenesis), this 
implies either that the cells comprising the microenvironment or niche in the testis is 
defective and thus is responsible for infertility. This makes defining the SSC niche and 
factors that mediate it critically important for addressing male infertility.  
It is clear that the somatic cells of the testicular seminiferous tubules, the Sertoli 
cells, constitute an essential part of the spermatogonial stem cell niche.  Specifically, 
Sertoli cell products, including glial cell line-derived neurotrophic factor (GDNF) plays 
an essential role in maintaining SSC number in the adult testis. Our experiment 
manipulates GDNF, a key factor in the niche, using a novel chemical-genetic approach. 
This approach allows for pharmacological manipulation of GDNF, and reduction of SSC 
numbers in a highly controlled manner. Once treatment ends, SSC numbers are rebuilt 
intrinsically. The goal is to identify molecules and mechanisms responsible for rebuilding 
a depleted stem cell pool. With this information, we predict that we can then decipher 
why stem cell numbers do not expand in men with SCO testes. Specifically, the major 
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experiment in this thesis measures the effects of depletion and then the restoration of 
GDNF signaling on the differentiation of SSCs and their immediate progeny, the 
undifferentiated transit amplifying progenitor spermatogonia. We hypothesize that when 
GDNF signaling is restored after 9 days of inhibition, numbers of SSCs and progenitor 
spermatogonia are rebuilt through suppressing the differentiation these cells.  
BACKGROUND 
Spermatogonial stem cells (SSCs) reside in a specific environment of the seminiferous 
tubules of the testes called the SSC niche. The niche is a physical location in the 
seminiferous tubules that provides the proper nutrients and signals from the surrounding 
cells and interstitial environment to maintain self-renewing SSCs (see Figure 2). Sertoli 
cells most directly influence the niche by providing the physical location in which SSCs 
are found, by adhering to spermatogonia, and by secreting factors necessary for 
maintaining their undifferentiated state. These large cells line the seminiferous tubules. 
Tight junctions form between adjacent Sertoli cells, creating what is referred to as the 
blood- testes barrier (see Figure 2). The tight junctions create the two compartments 
within the seminiferous tubules.  The area between the basement membrane and the tight 
junctions formed by Sertoli cells is called the basal compartment of the seminiferous 
tubules. The basal compartment represents the physical location of the SSC niche. It is 
separate from the luminal compartment of the tubules where the differentiating cells are 
undergoing meiosis and forming mature spermatozoa. (Oatley Brinster, 2013).  SSCs and 
progenitor spermatogonia in mouse testes express integrins (α and β), which are known to 
bind laminins expressed by Sertoli cells (Shinohara et al, 1999). Impaired expression of 
β1-integrin on SSCs in vitro resulted in reduced attachment to laminin molecules and 
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dramatically reduced the re-colonization of SSCs in recipient testes (Kanatsu-Shinohara 
et al, 2008). In vitro cultures and in vivo mouse models have led the field to identify three 
promising growth factors that maintain SSCs: FGF2, CSF-1, and GDNF.  There is 
compelling evidence for GDNF supporting SSCs, and GDNF’s effects on SSC self-
renewal are discussed below. FGF2 in addition to GDNF has been shown to be a 
necessary factor for long-term cultures of SSCs from mouse of specific genetic 
backgrounds (Kanatsu-Shinohara et al 2005). Colony Stimulating Factor-1 (CSF-1) has 
been shown to have effects on SSC self renewal in vitro; long-term cultures with CSF-1 
yielded an increase in the fraction of SSC verified by transplantation assays (Oatley et al. 
2009). Interestingly the total number of undifferentiated spermatogonia was not increased 
implying CSF-1 specifically affects spermatogonia self-renew and the balance between 
SSC and transit amplifying progenitor spermatogonia.  
Figure 1. 
 
Figure 1. (Oatley, Brinster 2012). These schematics represent the types of symmetric and 







Figure 2.  
 
Figure 2. (Oatley, Brinster 2012). A. This cartoon represents the seminiferous tubule 
architecture, and the SSC niche with surrounding cells/intersitum that directly or 
indirectly influence the niche. Stertoli cells adhere to SSC and secrete GDNF, FGF2, 
among many other factors nurturing SSC to sperm. Leydig cells are known for producing 
androgens which directly and indirectly support spermatogenesis. Interestingly they also 
secret CSF-1. The tight junctions between stertoli cells separate spermatogonia from 
differentiating spermatocytes undergoing meiotic divisions and further differentiation.  
 In mice and men, SSCs and progenitor spermatogonia combine to form a 
population of undifferentiated spermatogonia with specific morphological characteristics. 
In mice the undifferentiated A spermatogonia have three subdivisions:  Asingle  (As), Apaired  
(Apr), and Aaligned (Aal). The classic model proposes the As population contains the SSCs. 
When these cells divide, they form either more As spermatogonia that continue to act as 
SSCs or they form As cells that function as transit amplifying progenitor spermatogonia. 
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The division of these progenitors forms two linked Apr cells, which then undergo another 
division forming a chain of Aal cells (de Rooij, 2000). These Aal can continue to divide in 
aligned linked chains acting as progenitor undifferentiated transit amplifying cells 
(Oakberg, 1971). It is important to note that not all As cells are SSCs. SSCs as defined by 
serial transplantation assays number approximately 3,000 in a mouse testis (Nagano, 
2003), while the As number is around 30,000 per testes (Parker et al. 2014).  
 Accurately identifying the true SSCs has been challenging because of the 
difficulty teasing them away from the undifferentiated transit amplifying spermatgonia.  
A number of potential molecular markers for these cells have been considered, including 
as GFRα1, PLZF, Neuro3, Nanos2, Lin28, and most recently ID4. Yet none of these has 
successfully distinguished the SSCs from the undifferentiated progenitor spermatogonia 
(de Rooji, Griswold 2000). GFRα1 is the cell membrane ligand for GDNF and is 
commonly used to define a population of undifferentiated SSCs in the testis. GFRα1 is 
considered a marker of more primitive type A undifferentiated spermatogonia possessing 
stem cell potential (Buageaw et al, 2005). GDNF’s critical role on SSC self-renewal has 
been elucidated through in vitro and in vivo experiments. In vitro adding GDNF to 
culture media is necessary for the long-term maintenance and expansion of SSCs (Kubota 
et al, 2004). In vivo, seminiferous tubules of mice overexpressing GDNF had an 
overproduction of undifferentiated spermatogonia and lacked later stages (Meng et al. 
2000). Our lab has shown that inhibition of GDNF signaling for 7 days leads to a 
dramatic decrease in the total number of undifferentiated spermatogonia, with a lesser 
decrease in SSC numbers (Parker et al. 2014).  
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Acting downstream from GDNF in the spermatogonial lineage are kit ligand and 
its receptor, c-kit. Experiments with mutant c-kit protein showed that c-kit is necessary 
for the irreversible transition from type A undifferentiated spermatogonia to 
differentiating type A1 (de Rooji et al. 1999). c-kit is also critical for the development of 
type A differentiating spermatogonia from A1 to A4. In vivo experiments administering 
anti- c-kit antibodies caused depletion of A1 to A4 spermatogonia while the 
undifferentiated spermatogonia remained intact (Yoshinaga, 1991). Thus, c-kit is vital for 
and a marker of spermatogonial differentiation. Parker et al. showed that with the 
inhibition of GDNF for 7 days, the fraction of As undifferentiated GFRα1
+ cells 
expressing c-kit increased from 0.008 to 0.40. Our lab noted that control mice have few 
cells in which c-kit is co-localized with the undifferentiated spermatogonia cell surface 
marker GFRα1. In theory cells expressing c-kit are type A differentiating spermatogonia, 
while cells expressing GFRα1 are type A undifferentiated spermatogonia, and cell 
expressing both c-kit and GFRα1 are undifferentiated spermatogonia undergoing the 
transition from As/pr/al to A1.  
 The question posed by the Wright lab is how do GFRα1+ spermatogonia respond 
to a reintroduction of GDNF signaling after 9 days of inhibition. To address this, we used 
an in vivo chemical-genetic approach inhibiting GDNF signaling and investigating the 
role it plays on SSCs by measuring the cell number, differentiation, and replication of 
undifferentiated spermatogonia over time. GFRα1 functions at the cell surface as the 
ligand-binding subunit of the GDNF receptor, and signal transduction then occurs 
through the receptor tyrosine kinase RET. RET signaling requires an activating 
phosphorylation in its active site (see Figure 3). In our mutant mouse model the RET 
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active site possess a mutation which under normal conditions has no effect on the 
animal’s spermatogonia. But pharmacological intervention with a bulky-ATP inhibitor 
blocks the RET active site from activating phosphorylation effectively inhibiting GDNF 
signaling (Figure 3.)(Savitt et al., 2012). Inhibiting GDNF drastically perturbs the niche 
and therefore the SSCs. Our work utilizes this perturbation to study the response 
undifferentiated spermatogonia measuring cell number, replication, and specifically in 
this thesis, differentiation. GDNF is known to maintain undifferentiated spermatogonia in 
vitro and in vivo, the thesis analyzes the differentiation of these undifferentiated cells 
after inhibition and restoration of GDNF signaling. 
Figure 3.  
 
Figure 3. This is an illustration of the interacting of GDNF-GFRα1-Ret at the cell 
surface. The left illustration demonstrates activating phosphorylation and signaling 






MATERIALS AND METHODS 
-Animals and Their Treatment 
 The murine model used were black6 mice with a V805A mutation in the ATP 
binding site of the tyrosine kinase Ret (Savitt et al., 2012). Homozygous Ret mutant mice 
were identified used polymerase chain reaction analysis of their genomic DNA. The 
primers used crossed the 5’ LoxP site of the targets construct:  
Ret F (36580): CCTTGGGCCTGCTGAGCACGGG  
RET R (36858): GGAGGCAGGAAGGCCTGTGC 
PCR conditions were as follows; 4 minutes at 95 C followed by 35 cycles of 30 seconds 
at 95 C, 45 seconds at 57 C, 45 seconds at 72 C, followed by a 7-minute incubation at 72 
C.  
To inhibit GDNF signaling Ret mutant (V805A) aged 90-120 days were injected 
subscapularly once daily for nine day at 24 hour intervals with 43.7 mg/kg body weight 
1NA-PP1-HCl, which is dissolved in ethanol at a concentration of 62 mg per ml 
(described at NA-PP1 henceforth) which was synthesized and prepared for injection 
solution as described in (Savitt et al., 2012). Control mice were injected with 100 
microliters of vehicle plus ethanol (saline:cremophor:ethanol::28:8:3.6) per 10-grams of 
body weight.   
Following treatment 4 to 7 animals were sacrificed at Day 10 (one day following 
the last injection of NA-PP1), Day 14, and Day 22. Results were gathered from two 
separate trials over the course of 2015-2016. The Johns Hopkins University Institutional 
Animal Care and Use Committee approved this protocol.  
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-Collection of tissue and Immunocytochemistry  
Whole testes were dissected from the animal, weighed, and 12-20 seminiferous 
tubules per animal were fixed for 1 hour at 4 C in 10% paraformaldehyde 10% methanol 
in phosphate-buffered saline (PBS; pH=7.3-7.4 pH). Methanol was used to perfuse the 
cell membrane exposing the intracellular c-Kit epitope for antibody binding. Specimens 
were fixed within 30 minutes of sacrifice to mitigate degradation of relevant proteins.  
After fixation the tubules were washed 6 times for 15 minutes each in PBS at 
room temperature. Immediately afterwards, the samples were blocked for 1 hour at room 
temperature in 1% Bovine Serum Albumin (BSA) in PBS. The samples were then 
incubated in primary antibodies overnight at 4 C. c-kit rat anti-mouse (CD117, CBL1360, 
clone ACK2) at a 1:50 dilution in 250 microliter of PBS-BSA 1%- Triton x-100 at 0.1% 
(PBS-BT) per well. GFRα1 goat anti-mouse (AF560, R & D systems) at 1:100 dilutions 
in 250 microliter PBS-BT per well. The GFRα1 primary antibody was a polyclonal IgG 
that had been affinity purified against GFRα1, and the c-Kit was a rat monoclonal IgG2b, 
kappa isotype.  
The next day the samples were washed 6 times for 15 min each wash in PBS-BT 
at room temperature. After that secondary antibodies were applied for two hours at room 
temperature void of light. The secondary antibodies were made in 1:200 dilutions in 250 
microliters of PBS-BT. c-Kit secondary is an AlexaFluor 488-conjugated donkey anti-rat 
IgG, and GFRα1 is an AlexaFluor 555 conjugated donkey anti-goat IgG. The tubules 
were again washed 6 times for 15 min each in PBS-BT at room temperature. Finally 5-10 
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tubules per animal were then whole-mounted on glass slides with VectaShield 
fluorescence.  
c-Kit and GFRα1 were selected because they are markers for differentiating and 
undifferentiated type A spermatogonia respectively.  In normal, mature testes, c-Kit 
expression is present from A1 to preleptotone spermatocytes, and is necessary for 
undifferentiated single, paired, aligned spermatogonia transitioning to differentiating type 
A1 spermatogonia. GFRα1 is a marker of undifferentiated spermatogonia and is 
expressed in As, Apr, and Aal.  
-Microscopy 
The immunofluorescence staining of seminiferous tubules was imaged using a 
Zeiss LSM 710NLO-Meta Confocal Microscope (25X lens). Cells in the basal aspect of 
seminiferous tubules were imaged according to the confocal specifications shown below. 
Signals produced by the green and red fluorchromes were captured separately, and 
subsequently merged. 
2-10 tubules were scanned and imaged per animal, dependent on length and 
number of GFRα1+ cells present (i.e. controls had greater than 50 GFRα1+ cells per 
tubules, day 10 on average less than 10 cells per tubule).  
c-Kit Staining: 488 (Green Laser): 
 Laser: 75.0% 
 Pinhole: 46.5 units 
 1.00 Airy Units=2.2 micron section  
 Gain Master: 750 
 Digital Master: 125 
 Digital Offset: 1.0 
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GFR α1 Staining 543 (Red Laser): 
 Laser: 15.0%  
 Pinhole: 42.9 units  
 0.81 Airy Units=2.2 micron section  
 Gain Master: 760 
 Digital Master: 125 
 Digital Gain: 1.0 
-Statistics 
 Data from the two replicate experiments were pooled and data analyzed both by 
ANOVA and a nested ANOVA using StatView.  In this analysis, day and cell type were 
nested within the effects of treatment. Differences between means were tested by Fisher’s 
PLSD test.  
RESULTS 
-Confocal Microscopic Identification of Cells expressing GFRα1, c-kit or both 
marker proteins in control seminiferous tubules and in tubules collected at day 10 (1 
day after the last injection of 1Na-PP1), or at days 14 or 22.   
We used confocal microscopy to image between 2 and 10 seminiferous tubules 
per animal in order to gain a clear understanding of the relative numbers of GFRα1+, c-
kit-, GFRα1+, c-kit+ and GFRα1-, c-kit+ cells, the relative amount GFRα1 expressed per 
cell, and the morphologies of the cells in the different experimental groups.  The four 
groups control, day 10, day 14, and day 22 showed apparent differences qualitatively and 
quantitatively in the number, morphology, and staining intensity of GFRα1+ cells. For the 
purposes of illustration, we present the results for GFRα1, c-kit separately and also 
merged in one image.  
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Image 1. Control Mice
 
Image 1. Control Mice. Left, combined red/green image. Middle, red GFRα1+. Right, 
green c-Kit+. The white arrow indicates the only cell in this image expressing both. 
Approximately 2-4 tubules per animal were analyzed per the control group.  
Image 1 is a representative image of a tubule from a control animal. 9 control 
animals were injected with vehicle on the same schedule as treatment animals, and 
collected and imaged using the same methods. The left most image is a composite of both 
green (c-kit) and red (GFRα1) channels. The center image is strictly the red GFRα1 
channel, and the right is strictly the green c- + 
cells do not express c-kit. However, the white arrow identifies a GFRα1+ cell that also 
expressed c-kit.  
In the center of the images there are two separate chains of Aal cells in the upper 
and lower middle segment of seminiferous tubule. Aligned chains of GFRα1+ cells are 
seen throughout the control tubules. Chain lengths of four and eight intercellular-bridged 
cells are the most common, although longer chains are regularly observed. The grouping 
of cells to the left of the images is a fragmenting chain that contains one c-kit+ GFRα1+ 
co-stained cell. Co-stained cells normally occur in or near chains of cells, and often only 
one marker (c- t co-
stained cells are rare in control, while long chains of brightly green stained c-kit+, 
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- spermatogonia are numerous in controls. Looking at the right panel, c-kit+ cells 
are ubiquitous in control tubules existing in chains (Image 1) of cells connected by 
+
 cells. 
Image 2. Day 10 Mice  
 
Image 2. Day 10 mice. Left, combined red/green image. Middle, red GFRα1+. Right, 
green c-Kit+. The white arrows indicate two cells in this image expressing both markers. 
The less intense c-kit staining at the top of the image is due to mounting of the tubule 
section on the slide and can be observed in greater intensity when the microscope is 
focused on that section.  
This is a representative image from a Day 10 animal, and thus, sacrificed 24 hours 
after the last of 9 daily injections of 1NA-PP1. Day 10 has notably fewer GFRα1+ cells 
present than any other time point because of this approximately 6 to 10 tubules were 
analyzed per animal. Almost all of the GFRα1+ cells at this time point fluoresce 
noticeably less brightly than control cells, and chains longer than four cells are very rare. 
Like the cells in Image 2, the morphology of day 10 GFRα1+ cells is generally larger and 
more asymmetrical than the circular Aal control chains. Of the remaining GFRα1
+ cells at 
day 10 co-staining with c-kit is more numerous than any other time point. The white 
arrows indicate two co-stained cells that are faintly expressing GFRα1. Most of the 
GFRα1+ c-kit+ cells at this time point are faintly expressing GFRα1 and strongly 
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expressing c-kit. Generally, c-kit staining is present throughout the tubules is similar to 
control with chains or tiling (seen here in Image 2) of cells.  
Image 3. Day 14 Mice  
 
Image 3. Day 14 Mice. Left, combined red/green image. Middle, red GFRα1+. Right, 
green c-Kit+. The white arrow indicates the only cell in this section expressing both. This 
tubule is smaller than the others represented in this thesis it is a 25x magnification image.  
This is a representative image from a Day 14 animal, and, thus, sacrificed 5 days 
after the last of 9 daily injections of 1NA-PP1. At day 14 GFRα1+ cells are more 
numerous than the sparsely populated day 10 tubules but still drastically lower in number 
than in control tubules. It is common for GFRα1+ cells at day 14 to fluoresce noticeable 
less brightly than cells in control mice. In this image faint chains of cells are present at 
the bottom-middle and right of the image. Short chains like these of 4-8 cells are common 
but longer chains longer than 8 are very rare. The c-kit staining throughout the tubules is 
similar to control with chains or tiling of cells ubiquitous throughout the tubules. Co-
staining at day 14 is similar to day 10 with co-stained cells showing faint GFRα1 
fluorescence and brighter c-kit signal.   
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Image 4. Day 22 Mice
 
Image 4. Day 22 Mice. Left, combined red/green image. Middle, red GFRα1+. Right, 
green c-Kit+. 
This is a representative image from a day 22 animal, and, thus, sacrificed 13 days 
after the last of the daily injections of 1NA-PP1. GFRα1+ are frequently in chains or 
clumps of over 16 cells, which are not often seen in controls. The intensity of 
fluorescence of GFRα1+ cells is similar to control cells, unlike many of the day 10 and 14 
cells. Interestingly, c-kit cells are greatly reduced in number in foci of the tubules, but do 
appear in normal chains in other parts of the tubule. The reduction in c-kit+ cells is 
illustrated in this panel. At day 22 entire 4-8 cell chains are GFRα1+ c-kit+, unlike control 
where only a cell or two associated with a chain is GFRα1+ c-kit+.  
-Quantitative Analysis of the Changes in Differentiation of GFRα1+ spermatogonia 
following restoration of GDNF signaling.  
 The analysis described suggested that following restoration of GDNF signaling, 
the fraction of GFRα1+ spermatogonia that were differentiating was reduced. To test this 
quantitatively, we enumerated both GFRα1+ c-kit- spermatogonia and GFRα1+ c-kit+  
spermatogonia in order to calculate the fraction of all GFRα1 expressing c-kit (i.e. 
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differentiating) in control mice, and in mice collected on days 10, 14 and 22 of the 
experiment.  
Graph 1 illustrates general trends in the mean ratio of c-kit+ GFRα1+ 
spermatogonia as a fraction of total GFRα1+ spermatogonia for controls and for each 
treatment group. The animals collected at day 10 exhibited the highest mean ratio of c-
Kit+ GFRç1+/GFRα1+ spermatogonia, with a 7.25-fold increase over control. This is 
indicative of the effect losing GDNF signaling has on undifferentiated spermatogonia as 
the last treatment injection was only 24- hours prior. Over time the ratio decreases to 3.6-
fold and 3.3- fold above control at Day 14 and Day 22 respectively. Scheffe’s tests 
confirmed a significant difference between control and Day 10 of treatment, with a p 
value <0.0001 (null defined at p value <0.05) (See Appendix table 1.). Fischer’s PLSD 
also confirmed a significant difference between control and Day 14 with p value 0.0056. 












Graph 1.  
 
Graph 1. The mean ratio of is reported by assessing the ratio of GFRα1+cKit+ /GFRα1+ for each animal 
and averaging the ratios together by treatment group. Day 10; 7.25-fold increase in the ratio of 
spermatgonia marked for differentiation compared to control. Day 14;3.6-fold increase. Day 22; 3.3-fold 
increase. Bars with different superscripts differ statistically.  
Graph 2 stratifies each treatment group by cell type As, Apr, Aal and there are 
interesting differences between cell types during restoration of GDNF signaling. In As, 
the population classically hypothesized to contain most of the self-renewing stem cells, 
there is minimal change in the fraction of undifferentiated spermatogonia between days 
10 and 22, with ratios of 0.30 and 0.24 respectively. Meanwhile the Aal population, 
considered to contain mostly progenitor type cells, has a more drastic response to GDNF 
signaling restoration by Days 14 and 22. The mean ratio of c-kit+ GFRα1+ / GFRα1+ 
spermatogonia drops from 0.47 at day 10, to 0.21 at day 14, and 0.20 by day 22. Apr 




Graph 2. Fraction of GFRα1+cKit+ spermatogonia out of total GFRα1+ spermatogonia at control and 
three time points post treatment by cell type reported as the mean ratio. Day 10 (red bars) of treatment is 
associated with an increase in the ratio of cells moving toward differentiation for all types of spermato-
gonia 4.4-fold for As and 8-fold for Aal. By day 22 progenitor Aal spermatogonia show a dramatic decrease 
in the ratio of GFRα1+cKit+ differentiating spermatogonia to 3.6-fold above control. While the As 
population is more resistant to change remaining nearby at 3.4-fold above control. Nested ANOVA showed 
that there was overall a significant difference between the different treatment groups.  
DISCUSSION 
The research described in this thesis was motivated by the hypothesis that 
restoring GDNF signaling after 9 days of its inhibition would cause the remaining 
undifferentiated spermatogonia to suppress differentiation thereby restoring numbers of 
SSCs and progenitor spermatogonia in the testis. The work is part of the Wright lab’s 
larger goal to elucidate the role GDNF plays in rebuilding a depleted SSC population, 
and investigate possible causes and treatments of a type of male infertility called Stertoli 
Cell-Only. This phase of research involved inhibiting and restoring GDNF signaling and 
measuring the response in cell number, replication, and differentiation over time. The 
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of GFRα measured by co-expression of c-kit, is suppressed. 
However, even 13 days after restoration of signaling, the fraction of all 
GFRα -kit+ is still greater than controls. This is most 
evident in the As population. The significance of these results are best understood in the 
context of the data of Nicole Parker, a Ph.D. student in the Wright laboratory. In similar 
experiments she measured cell number and replication of GFRα1+ spermatogonia, and 
the combined results of the lab implicate how SSC repopulate the testis.  
The results of this thesis show a demarcation between As and Aal populations’ 
differentiation during restoration of GDNF signaling. The loss of GDNF signaling leads 
to a large decrease in the number of GFRα1+ cells. Many of the remaining GFRα1+ 
exhibited less intense fluorescence, and of those cells a large fraction exhibited c-kit co-
staining. GDNF is known in vitro and in vivo to support undifferentiated spermatogonia. 
Our data show that after 9 days of inhibited GDNF signaling, the fraction of GFRα1+ 
spermatogonia that express c-kit is increased 5.5-fold, indicating that differentiation is 
one cause for the loss of the cells.  However, on day 22, this fraction is reduced to 3.3-
fold. Quantitatively, the GFRα1+ Aal population has a drastic drop in expression in c-kit 
as signaling from 0.47 at day 10 to 0.20 at day 22. While in the As population only drops 
from 0.30 to 0.24 over the same time period, a somewhat perplexing result since SSC are 
considered to be a subset of this population. None-the-less, our results demonstrate that 
restoration of GDNF signaling gradually suppresses the increased rate of differentiation 
of As, Apr, and Aal spermatogonia. 
The importance of these observations is evident when they are viewed in the 
context of data generated by Nicole Parker, a Ph.D. student in the Wright laboratory, who 
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used the same chemical-genetic approach mentioned in this thesis to inhibit GDNF 
signaling for nine days and study the subsequent changes in numbers of GFRα1+ 
spermatogonia and in their replication. In fact many of the samples were collected from 
the same animals studied here.  
 
Graph 3. The graph indicates the mean number of GFRα1+ spermatogonia per mm2 of 
the seminiferous tubule and the standard error of the mean. For each cell type at 
recovery time points the cell number was significantly reduced from controls indicated by 
2-way ANOVA. A significant increase in recovered cell number was shown at day 28 in 
As and Apr cells compared to day 14 and at all days Aal compared to day 10. (*) p<0.05 
(****) p<0.0001 by post-hoc comparison tests.  
Nicole first asked how the As, Apr, and Aal GFRα1
+ spermatogonia responded by 
cell number.  She used very similar immunocytochemistry and microscopy techniques to 
the ones described in this thesis. Nicole showed that inhibition of GDNF signaling for 
nine days drastically reduces the number of the GFRα1+ in all cell. The populations of As 
and Aal GFRα1
+ spermatogonia seem to responded independently to inhibition and 
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restoration of GDNF signaling. The Aal population sees a statistically significant increase 
in population at day 14 and continues a steady increase in number thereafter. While the 
As population does not exhibit a statistically significant increase until day 28.  
Graph 4.  This graph shows the effect of a nine day treatment of NA-PP1, inhibition of 
GDNF signaling, on replication of GFRα1+spermatogonia during the observed recovery. 
The mean and standard error of mean in replication is displayed. The data shows a 
significant increase in replication from control indicated by 2-way ANOVA. (*) p<0.05, 
(***) p<0.001.  
Nicole also examined replication in the same group of animals using EdU staining 
to identify replicating cells. All populations of GFRα1+ spermatogonia measured here 
respond to the restoration of GDNF signaling with an increase in replication. 
Interestingly the As population has the most drastic response at day 14. The As population 
has a large 4- fold increase in replication at day 14 of the GDNF recovery experiment 
then drops near control levels by day 18. While Apr and Aal populations see only a 1.5-
23 
fold increase in replication at day 14 and maintain similarly high replication levels 
through day 22.  
Form Nicole’s data and results of this thesis a hypothesis can be formed, the 
undifferentiated spermatogonia response to a restoration of GDNF signaling by building 
progenitor populations first. Her data shows the As population, classically thought to 
contain the SSCs, reacts to restoration of GDNF signaling by increasing replication 
drastically at day 14. However, cell numbers are not significantly increased until day 28. 
In contrast the Aal population, classically considered undifferentiated progenitor transit 
amplifying spermatogonia, responses to a reintroduction of GDNF signaling with a slight 
increase in replication and a quick dramatic increase in cell number. Combining Nicole 
work with the results described in this thesis implies a restoration of GDNF signaling has 
different affects on SSC and undifferentiated transit amplifying progenitor spermatogonia. 
The As population acts by increasing replication and differentiation, producing cells that 
leave the population functioning for transit amplification. The Aal population responses to 
re-introduction of GDNF signaling by suppressing differentiation to increase cell number. 
Hypothetically, this re-establishes a large pool of transit amplifying spermatogonia in an 
effort to continue spermatogenesis. However, the combined work demonstrates that after 
the restoration of the progenitor spermatogonia, the numbers of As cells increases, and 
presumably, the SSCs.  The combined work implies a restoration of GDNF signaling has 
different effects on SSC and undifferentiated transit amplifying progenitor spermatogonia. 
This nuanced response indicates GDNF may act in coordination with other extrinsic 
signaling molecules in order to sequentially rebuild the numbers of transit amplifying 
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